These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26371477)

  • 1. Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study.
    Yuan Y; Che X; Ni Z; Zhong Y; Qi Y; Shao X; Wang Q; Cao L; Zhang M; Xie Y; Qi C; Tian L; Mou S
    PLoS One; 2015; 10(9):e0137870. PubMed ID: 26371477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
    Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
    Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M; Li W; Zou G; Zhang C; Fang J
    Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed Oxford classification-based clinicopathological nomogram for predicting short-term renal outcomes in IgA nephropathy after acute kidney injury.
    Zhang L; Zhuang X; Liao X
    Eur J Intern Med; 2018 Jun; 52():60-66. PubMed ID: 29395936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of C1q deposition with renal outcomes in IgA nephropathy.
    Lee HJ; Choi SY; Jeong KH; Sung JY; Moon SK; Moon JY; Lee SH; Lee TW; Ihm CG
    Clin Nephrol; 2013 Aug; 80(2):98-104. PubMed ID: 23587123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y; Ishida H; Shimizu T; Tanabe K
    Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y; Zhu L; Zhou T; Zhang Q; Shi S; Liu L; Lv J; Zhang H
    PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated model of disease progression in IgA nephropathy.
    Magistroni R; Furci L; Leonelli M; Masellis M; Ligabue G; Lucchi L; Lupo A; Brezzi B; Gambaro G; Manganelli L; Pedrazzi G; Ricardi M; Bormioli L; Albertazzi A
    J Nephrol; 2006; 19(1):32-40. PubMed ID: 16523423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
    Han SH; Kang EW; Park JK; Kie JH; Han DS; Kang SW
    Nephrol Dial Transplant; 2011 May; 26(5):1570-5. PubMed ID: 20841490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy.
    Shen PC; He LQ; Tang Y; Wang Q; Wang W; Li J
    J Investig Med; 2010 Mar; 58(3):560-5. PubMed ID: 20215916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.
    Ni Z; Yuan Y; Wang Q; Cao L; Che X; Zhang M; Xie Y; Qi C; Mou S
    J Transl Med; 2014 Jul; 12():194. PubMed ID: 25011573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
    Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
    Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a prognostic nomogram for IgA nephropathy.
    Liu J; Duan S; Chen P; Cai G; Wang Y; Tang L; Liu S; Zhou J; Wu D; Shen W; Chen X; Wu J
    Oncotarget; 2017 Nov; 8(55):94371-94381. PubMed ID: 29212234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.